StudyRareStudyRare

Multiple primary cancers

Log in to star

Last updated Nov 10, 2026

Log in to add personal notes on this page.

A patient with two or more separate primary cancers (not metastases from a single tumor), or a strikingly cancer-rich family history. Both situations elevate prior probability of a hereditary cancer syndrome from baseline (~10% of all cancers) into the range where multi-gene panel testing is justified, often pre-test counseling-required by insurers.

The combination of cancers narrows the syndrome before the panel is sent. Pattern recognition compresses what would otherwise be a 100-gene fishing expedition into a targeted question.

  • Two primary cancers in one organ (e.g. metachronous bilateral breast) is itself a syndrome signal, even without a family history.
  • Synchronous endometrial and ovarian (in a young woman) is classically Lynch.
  • A clean-looking family with three of the LFS cancers in close relatives still counts.
  • The cancer count in a family matters less than the types and ages.
  • Three-generation pedigree with cancer type, age at diagnosis, and bilaterality. Update it at every visit; relatives develop cancers between appointments.
  • Pathology re-review with attention to molecular markers (MSI/IHC for Lynch, IHC for SMARCB1 loss in rhabdoid tumors, FH IHC in HLRCC-suspect RCC).
  • Multi-gene cancer panel scoped to the phenotype. Most centers default to BRCA-focused panels for breast/ovary patterns and a broader 50 to 100 gene panel for ambiguous family histories.
  • Take the pedigree before sending the panel; it changes which panel you order.
  • Bilateral breast cancer under 50 even with a "negative" family history still warrants testing.
  • A clean panel does not rule out a hereditary syndrome. Variants in non-coding regions, deep intronic splice variants, and undiscovered genes still happen.